Sumatra, Justin B.

HRN: 21-50-16  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/08/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/08/2022
06/15/2022
IV
1g
Q6
Pneumonia
Waiting Final Action 
06/08/2022
CEFTRIAXONE 1G (VIAL)
06/08/2022
06/15/2022
IVT
2GM
OD
Acute Gastroenteritis, AKI
Waiting Final Action 
06/08/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/08/2022
06/15/2022
IVT
450mg
OD
Acute Gastroenteritis, AKI
Waiting Final Action 
06/09/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/09/2022
06/16/2022
IV
500mg
Q8
Amoebiasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: